Dividend Logo Green Small
MENU
Advertisement.

GNWSD:Stagezero Life Sciences Ltd - Stock Price Quote and Dividend Data

GNWSD STOCK PRICE LATEST CLOSE

$0.68

EXCHANGE

OTCBB

GNWSD

Stagezero Life Sciences Ltd Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
GNWSD

Stagezero Life Sciences Ltd Stock Price Information

GNWSD Stock Price Latest Close$0.68
52-Week Low/High Stock Price$0.17 - $0.89
Percent Held by Institutions0.00%
Revenue$283,969
Net Income$708,360
Cash Flow$-588,680
EPS0.00%
Market Cap$1,048,320
PE Ratio0
PE Ratio to Industry29%
Debt-Equity Ratio999,999.02%
Debt-Equity to Industry3.50%
Total Return Last 12 Months-7.37%
Total Return Last 3 Years15.29%
Total Return Last 5 Years-60.87%
Latest Trade DateOct. 13, 2020
GNWSD

Stagezero Life Sciences Ltd Annual Stock Dividends

No Data available for Payment History.

GNWSD

Stagezero Life Sciences Ltd Dividend Payment History

No dividends retrieved for GNWSD
GNWSD

Stagezero Life Sciences Ltd Other Dividend Details

Stagezero Life Sciences is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. Co. has been granted two foundational U.S. patents for its core platform technology, the Sentinel Principle®, which has the power to detect and stage virtually any disease or medical condition from a simple blood sample. Co. is applying the Sentinel Principle® in areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. Co.'s product include ColonSentry™, a blood-based test to assess an individual's current risk for colorectal cancer.

Web Sitewww.genenews.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Stagezero Life Sciences Ltd Dividend Stock News and Updates

Sep. 26, 2020CLOSE PRICE INCREASE: Stagezero Life Sciences Ltd (OTCBB: GNWSD) on 09-26-2020 increased close price > 10% from $0.56 to $0.62

Sep. 25, 2020CLOSE PRICE DECREASE: Stagezero Life Sciences Ltd (OTCBB: GNWSD) on 09-25-2020 decreased close price > 10% from $0.69 to $0.56

Sep. 24, 2020CLOSE PRICE DECREASE: Stagezero Life Sciences Ltd (OTCBB: GNWSD) on 09-24-2020 decreased close price > 10% from $0.78 to $0.69

Sep. 22, 2020CLOSE PRICE INCREASE: Stagezero Life Sciences Ltd (OTCBB: GNWSD) on 09-22-2020 increased close price > 10% from $0.65 to $0.77

More Stagezero Life Sciences Ltd Dividend News
Biotechnology Dividend Stock News and Updates

Apr. 09, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-09-2025 decreased stock price > 10% from $0.40 to $0.27

Apr. 09, 2025MAZE STOCK PRICE DECREASE: Maze Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $8.92 to $7.57

Apr. 09, 2025KANT STOCK PRICE DECREASE: Kineta Inc on 04-09-2025 decreased stock price > 10% from $0.35 to $0.30

Apr. 09, 2025ORKA STOCK PRICE DECREASE: Oruka Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $7.62 to $6.78

Apr. 09, 2025XCUR STOCK PRICE DECREASE: Com Par $0.0001/Exicure Inc on 04-09-2025 decreased stock price > 10% from $12.80 to $11.39

Apr. 09, 2025BIVI STOCK PRICE DECREASE: Cl A Par $0.0001/BioVie Inc on 04-09-2025 decreased stock price > 10% from $0.80 to $0.71

Apr. 09, 2025ARTV STOCK PRICE DECREASE: Artiva Biotherapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.31 to $1.92

Apr. 09, 2025ENTO STOCK PRICE DECREASE: Com Par $0.0001 (New)/Entero Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.49 to $0.42

Apr. 09, 2025APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 04-09-2025 decreased stock price > 10% from $1.30 to $1.13

Apr. 09, 2025RKVTF STOCK PRICE DECREASE: Rakovina Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.06 to $0.05

More Biotechnology Dividend News
X
Search Dividend Investor